Domainex's Research Director, Prof.Trevor Perrior will be presenting at this key industry drug discovery event.  His talk is entitled:

Is it real, or is it virtual?  Using the Domainex technology platform to identify novel inhibitors of lysine methyltransferases                       

Abstract: Using its Combinatorial Domain Hunting and LeadBuilder platform technologies, Domainex has cloned a number of PKMT SET domains, and has identified novel classes of drug-like inhibitors. This powerful combination of virtual and library screening, as well as fragment-based drug design, is applicable to a wide-range of enzyme and protein-protein interaction targets nominated by Domainex or its collaborators.

For more information about this event, please see: http://www.discoveryontarget.com/